Chu Limoges

Limoges 87042

2 studies enrolling now · 7 studies all time

What they study most

AVM, Acute Myeloid Leukemia, Alzheimer's Disease, Arteriovenous Malformations, BAVM, Coagulopathy, Diabetes Mellitus, Type 2, Metastatic Non-small Cell Lung Cancer, NASH - Nonalcoholic Steatohepatitis, Ruptured Brain Arteriovenous Malformation, Severe Sepsis, Unruptured Brain Arteriovenous Malformation

Studies at this site

• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
• Treatment of Brain AVMs (TOBAS) Study — Recruiting now
• Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Stopped early
• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated — Stopped early
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — Completed
• Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy — Completed
• A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) — Completed